Production (Stage)
Chemed Corporation
CHE
$569.57
$8.131.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.52% | 7.37% | 6.83% | 6.79% | 5.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.52% | 7.37% | 6.83% | 6.79% | 5.96% |
| Cost of Revenue | 9.62% | 7.60% | 4.98% | 3.76% | 5.41% |
| Gross Profit | 6.54% | 6.95% | 10.34% | 12.64% | 6.96% |
| SG&A Expenses | 2.10% | 6.05% | 6.03% | 9.79% | 9.95% |
| Depreciation & Amortization | 2.24% | 3.59% | 4.71% | 5.42% | 4.31% |
| Other Operating Expenses | 97.51% | -- | -168.47% | -170.26% | -195.42% |
| Total Operating Expenses | 7.91% | 7.15% | 4.95% | 4.81% | 6.10% |
| Operating Income | 11.99% | 8.59% | 18.27% | 18.85% | 5.16% |
| Income Before Tax | 12.91% | 14.01% | 24.52% | 28.89% | 15.04% |
| Income Tax Expenses | 26.95% | 25.18% | 28.39% | 16.75% | 4.85% |
| Earnings from Continuing Operations | 8.94% | 10.82% | 23.37% | 32.86% | 18.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.94% | 10.82% | 23.37% | 32.86% | 18.29% |
| EBIT | 11.99% | 8.59% | 18.27% | 18.85% | 5.16% |
| EBITDA | 10.68% | 7.97% | 16.61% | 17.22% | 5.36% |
| EPS Basic | 10.36% | 11.17% | 22.72% | 31.59% | 17.00% |
| Normalized Basic EPS | 12.18% | 15.28% | 24.77% | 28.58% | 14.80% |
| EPS Diluted | 10.52% | 11.14% | 22.61% | 31.55% | 17.00% |
| Normalized Diluted EPS | 12.34% | 15.20% | 24.54% | 28.44% | 14.71% |
| Average Basic Shares Outstanding | -1.25% | -0.17% | 0.55% | 0.95% | 1.10% |
| Average Diluted Shares Outstanding | -1.40% | -0.08% | 0.74% | 1.05% | 1.18% |
| Dividend Per Share | 20.25% | 15.38% | 10.39% | 5.26% | 5.33% |
| Payout Ratio | 0.09% | 0.04% | -0.10% | -0.20% | -0.10% |